A Study of NKTR-262 in Combination with NKTR-214 and with NKTR-214 Plus Nivolumab In Patients with Locally Advanced or Metastatic Solid Tumors of Urothelial or Renal Origin (REVEAL)

A Study of NKTR-262 in Combination with NKTR-214 and with NKTR-214 Plus Nivolumab In Patients with Locally Advanced or Metastatic Solid Tumors of Urothelial or Renal Origin (REVEAL)

Trial Category:
Genitourinary
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Nebraska Cancer Specialists, Omaha, NE
 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members